Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
Estimates Beat
|
Expensive Star
625.6500
-19.85
(
-3.08
%)
NSE
Apr 25, 2025
15:31 PM
New 52W High in past week
Volume:
7.1M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
28 Jul 2022
Estimates Beat
625.65
-3.08%
Laurus Labs (BUY): Synthesis business saves the day
Buy:
Laurus Labs Ltd.
by
BOB Capital Markets Ltd.
Target: 645
Recommendation
BOB Capital Markets Ltd.
Q1 revenue/EBITDA came in 5%/8% above consensus and grew 20%/ 15% YoY to Rs 15.4bn/Rs 4.5bn
Laurus Labs Ltd. has an
average target
of 621.00 from 4 brokers.
More from Laurus Labs Ltd.
Recommended
Five Interesting Stocks Today - April 25, 2025
The Baseline |
25 Apr 2025, 05:30PM
Market closes lower, Maruti Suzuki's Q4 net profit misses Forecaster estimates by 4%
Trendlyne Marketwatch |
25 Apr 2025, 03:56PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020